Lin, Pei-Tzu
Wang, Shu-Hui http://orcid.org/0000-0003-1028-5030
Chi, Ching-Chi http://orcid.org/0000-0001-5699-0283
Article History
Received: 3 January 2018
Accepted: 16 October 2018
First Online: 30 October 2018
Competing Interests
: Ms Lin and Dr Wang have no conflicts to report; Prof Chi received speaking fees from AbbVie Taiwan, Janssen-Cilag Taiwan, Novartis Taiwan, and Pfizer Taiwan.